Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,637 | 86,887 | 38,250 | 84,701 | 19,838 |
| Receivables | N/A | N/A | 663 | N/A | 600 |
| Other current assets | 0 | 0 | 0 | 0 | 247 |
| TOTAL | $75,811 | $88,938 | $41,731 | $87,831 | $20,685 |
| Non-Current Assets | |||||
| PPE Net | 1,875 | 2,727 | 3,568 | 3,686 | 693 |
| Other Non-Current Assets | 2,213 | 3,227 | 3,062 | 2,137 | 1,979 |
| TOTAL | $4,088 | $5,954 | $6,630 | $5,823 | $2,672 |
| Total Assets | $79,899 | $94,892 | $48,361 | $93,654 | $23,357 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,027 | 4,149 | 1,768 | 3,919 | 1,417 |
| Accrued Expenses | 10,121 | 7,253 | 4,432 | 3,596 | 2,595 |
| TOTAL | $15,237 | $12,374 | $7,065 | $8,020 | $4,012 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,988 | 4,078 | 5,307 | 16,116 | 54,475 |
| TOTAL | $2,988 | $4,078 | $5,307 | $16,116 | $54,475 |
| Total Liabilities | $18,225 | $16,452 | $12,372 | $24,136 | $58,487 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,022 | 15,064 | 10,938 | 3,658 | 1,250 |
| Common Shares | 2 | 1 | N/A | 4 | 1 |
| Retained earnings | -240,869 | -169,600 | -105,135 | -67,450 | -36,813 |
| TOTAL | $61,674 | $78,440 | $35,989 | $69,518 | $-35,130 |
| Total Liabilities And Equity | $79,899 | $94,892 | $48,361 | $93,654 | $23,357 |